Rice Hall James & Associates LLC purchased a new stake in CompoSecure, Inc. (NASDAQ:CMPO - Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 268,610 shares of the company's stock, valued at approximately $3,766,000. Rice Hall James & Associates LLC owned approximately 0.33% of CompoSecure as of its most recent SEC filing.
Several other large investors have also recently added to or reduced their stakes in the company. Pacific Ridge Capital Partners LLC acquired a new stake in shares of CompoSecure in the first quarter valued at $1,424,000. Boston Partners increased its position in CompoSecure by 40.8% in the 1st quarter. Boston Partners now owns 557,136 shares of the company's stock valued at $4,028,000 after acquiring an additional 161,333 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of CompoSecure by 165.4% in the second quarter. Renaissance Technologies LLC now owns 209,389 shares of the company's stock worth $1,424,000 after acquiring an additional 130,489 shares during the last quarter. Bailard Inc. acquired a new position in shares of CompoSecure during the second quarter worth approximately $259,000. Finally, Rhumbline Advisers grew its stake in shares of CompoSecure by 17.3% during the second quarter. Rhumbline Advisers now owns 19,521 shares of the company's stock valued at $133,000 after purchasing an additional 2,877 shares during the last quarter. 37.56% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several research analysts have issued reports on CMPO shares. Needham & Company LLC upped their price objective on CompoSecure from $15.00 to $16.00 and gave the stock a "buy" rating in a report on Thursday, August 8th. Lake Street Capital upped their price target on CompoSecure from $14.00 to $18.00 and gave the company a "buy" rating in a research note on Wednesday, October 2nd. Benchmark lifted their price objective on CompoSecure from $12.00 to $17.00 and gave the stock a "buy" rating in a research report on Wednesday, September 18th. Bank of America boosted their price objective on CompoSecure from $9.00 to $10.00 and gave the stock a "buy" rating in a report on Thursday, August 8th. Finally, Compass Point raised their target price on shares of CompoSecure from $11.50 to $14.50 and gave the company a "buy" rating in a research note on Tuesday, August 20th. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, CompoSecure currently has a consensus rating of "Moderate Buy" and a consensus price target of $15.07.
Check Out Our Latest Stock Analysis on CompoSecure
CompoSecure Stock Performance
CMPO traded down $0.16 during midday trading on Friday, reaching $14.95. 1,152,119 shares of the company were exchanged, compared to its average volume of 500,093. The stock has a market capitalization of $1.23 billion, a P/E ratio of 14.95, a PEG ratio of 1.11 and a beta of 0.78. CompoSecure, Inc. has a one year low of $4.61 and a one year high of $15.76. The stock's 50-day simple moving average is $13.55 and its 200 day simple moving average is $9.61.
CompoSecure (NASDAQ:CMPO - Get Free Report) last released its quarterly earnings data on Wednesday, August 7th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.01. CompoSecure had a net margin of 6.33% and a negative return on equity of 11.78%. The business had revenue of $108.57 million for the quarter, compared to analyst estimates of $102.22 million. During the same quarter last year, the firm earned $0.25 EPS. On average, research analysts anticipate that CompoSecure, Inc. will post 1.1 earnings per share for the current year.
Insider Activity at CompoSecure
In other CompoSecure news, Director Michele Logan sold 10,017,983 shares of CompoSecure stock in a transaction dated Tuesday, September 17th. The stock was sold at an average price of $7.55, for a total transaction of $75,635,771.65. Following the transaction, the director now directly owns 2,043,320 shares in the company, valued at approximately $15,427,066. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Michele Logan sold 10,017,983 shares of the stock in a transaction that occurred on Tuesday, September 17th. The stock was sold at an average price of $7.55, for a total transaction of $75,635,771.65. Following the completion of the sale, the director now directly owns 2,043,320 shares of the company's stock, valued at approximately $15,427,066. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jonathan Wilk sold 618,014 shares of CompoSecure stock in a transaction that occurred on Tuesday, September 17th. The shares were sold at an average price of $7.55, for a total transaction of $4,666,005.70. Following the completion of the transaction, the chief executive officer now directly owns 618,013 shares in the company, valued at approximately $4,665,998.15. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 10,867,586 shares of company stock worth $82,870,442 in the last quarter. Corporate insiders own 74.99% of the company's stock.
CompoSecure Company Profile
(
Free Report)
CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.
See Also
Before you consider CompoSecure, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CompoSecure wasn't on the list.
While CompoSecure currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.